Janssen
Website:
Address:
Macquarie Park, New South Wales, Australia
Biography:
At Janssen, we believe that scientific innovation is critical to better health care for people around the world. Along with a strong commitment to research within our own organization, we have made a commitment to partner with universities, research institutes and companies who share our vision and with whom we can work together providing the ideas and expertise to identify, develop and commercialize the therapies of tomorrow. In addition, we continue to look for new opportunities to work with licensing or acquisition firms to further support the establishment of early stage healthcare companies developing treatments of high unmet medical need. We understand and value the potential and exceptional results these partnerships can bring. Prostate cancer is one of our core areas of scientific research and development.
Janssen has a proven track record of managing successful partnerships from early to later stage discovery and development. We view partnerships as central to our business activities and this is reflected in our professional and flexible approach. We have an ongoing commitment to deliver the best value to our partners across all stages of a product life cycle, including leveraging our strong functional expertise across clinical research and development, regulatory, health economics and pricing, product launch management, sales and marketing.
If you are interested in partnering with Janssen in early stage prostate cancer research, please contact Kathy Connell, Senior Manager Innovation and Investment at kconnel6@its.jnj.com
Work Focus:
- Work Focus (Clinical): Cardiovascular Disease (including diabetes), Haematological malignancies, Immunology, Infectious diseases/ vaccines, Lung Cancer, Neuroscience, Prostate cancer
- Work Focus (Professional): R&D collaborations, Research partnerships, including post-docs, PhD's
